إعلان
إعلان
ADMA
ADMA Biologics, Inc.
17.88
USDبرعاية
-0.36
-1.96%
٠٢ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
17.98
+0.09
+0.51%
تقارير أرباح ADMA
النسبة الإيجابية المفاجئة
ADMA تفوق 18 من 40 آخر التقديرات.
45%
التقرير التالي
بيانات التقرير القادم
٠٢ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$142.44M
/$0.18
التغير الضمني من Q3 25 (Revenue/ EPS)
+6.12%
/+20.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
+21.18%
/+28.57%
ADMA Biologics, Inc. earnings per share and revenue
On ٠٥ نوفمبر ٢٠٢٥, ADMA reported earnings of 0.15 USD per share (EPS) for Q3 25, missing the estimate of 0.15 USD, resulting in a -1.96% surprise. Revenue reached 134.22 مليون, compared to an expected 133.14 مليون, with a 0.81% difference. The market reacted with a -8.72% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of 0.18 USD, with revenue projected to reach 142.44 مليون USD, implying an increase of 20.00% EPS, and increase of 6.12% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
٢٢ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.57
الفعلي
-$0.73
مفاجئة
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
١٩ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.25
الفعلي
-$0.19
مفاجئة
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
What were ADMA Biologics, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, ADMA Biologics, Inc. reported EPS of $0.15, missing estimates by -1.96%, and revenue of $134.22M, 0.81% above expectations.
How did the market react to ADMA Biologics, Inc.'s Q3 2025 earnings?
The stock price moved down -8.72%, changed from $15.37 before the earnings release to $14.03 the day after.
When is ADMA Biologics, Inc. expected to report next?
The next earning report is scheduled for ٠٢ مارس ٢٠٢٦.
What are the forecasts for ADMA Biologics, Inc.'s next earnings report?
Based on 4
analysts, ADMA Biologics, Inc. is expected to report EPS of $0.18 and revenue of $142.44M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان